510(k) Report

FDA applicant

Alembic, LLC

Mountain View, CA13 decisions2023–20260 recalls

FDA records 13 decisions for Alembic, LLC (Mountain View, CA) from 2023 to 2026: 13 510(k) clearances. Most are in product codes NRY (Catheter, Thrombus Retriever) and DQY (Catheter, Percutaneous). Since 2016 its 510(k)s took a median of 29 days from receipt to decision, against 116 for FDA’s reviews in the same codes and years. Its devices cite 12 predicates, 9 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Alembic, LLC’s devices, and how often a recall has named them.

FDA decisions per year

6in 2025

2023: 22024: 22025: 62026 (partial year): 3
2023high 6 (2025) · low 2 (2023)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2023.

FIG. 1 — Alembic, LLC by year, 2023–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Alembic, LLC’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report